doi:10.1126/science.aaa1348 48. Van Allen EM, Miao D, Schilling B, Shukla SA, Blank C, Zimmer L, et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science.(2015)350:207–11.doi:10.1126/science.aad0095 49. Carreno BM, Magrini V, Becker-Hapak M, Kaabinejadian S, Hunda l J, Petti AA, et al. A dendritic cell vaccine increases the breadth a nd diversityofmelanomaneoantigen-speciﬁcTcells. Science.(2015)348:803–8. doi:10.1126/science.aaa3828 50. OttPA,HuZ,KeskinDB,ShuklaSA,SunJ,BozymDJ,etal.Animmun ogenic personal neoantigen vaccine for patients with melanoma. Nature.(2017) 547:217–21.doi:10.1038/nature22991 51. Sahin U, Derhovanessian E, Miller M, Kloke BP, Simon P, Lower M , et al. Personalized RNA mutanome vaccines mobilize poly-speciﬁc therapeutic immunity against cancer. Nature.